A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin
Public ClinicalTrials.gov record NCT00456053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00456053
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Kyntra Bio
- Industry
- Enrollment
- 145 participants
Conditions and interventions
Conditions
Interventions
- FG2216 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2005
- Primary completion
- Not listed
- Completion
- Jun 30, 2007
- Last update posted
- Nov 5, 2007
2005 – 2007
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | — | — |
| Research Site | Little Rock | Arkansas | — | — |
| 3 Research Sites | Los Angeles | California | — | — |
| Research Site | Oakland | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Santa Clara | California | — | — |
| Research Site | Lauderdale Lakes | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Pembroke Pines | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | South Holland | Illinois | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Springfield | Massachusetts | — | — |
| Research Site | Kalamazoo | Michigan | — | — |
| Research Site | Pontiac | Michigan | — | — |
| Research Site | Flushing | New York | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Columbus | Ohio | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Allentown | Pennsylvania | — | — |
| Research Site | Hershey | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | Orangeburg | South Carolina | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Chesapeake | Virginia | — | — |
| Research Site | Fairfax | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00456053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2007 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00456053 live on ClinicalTrials.gov.